Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pessi

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, R Labianca, et al.
Analytical Biochemistry|January 16, 1999
A high-throughput radiometric assay for hepatitis C virus NS3 proteaseM Cerretani, L Di Renzo, S Serafini, et al.
European Journal of Immunology|October 1, 1991
Mycobacterial heat-shock proteins as carrier moleculesA R Lussow, C Barrios, J van Embden, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1987
Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 childrenG Del Giudice, H D Engers, C Tougne, et al.
Journal of Molecular Biology|June 15, 1999
Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studiesD O Cicero, G Barbato, U Koch, et al.
European Journal of Biochemistry|September 5, 2001
ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serumO Minenkova, N Gargano, A De Tomassi, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) studyS Cascinu, S Barni, R Labianca, et al.
British Journal of Cancer|April 20, 2001
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancerA Sobrero, A Guglielmi, M Cirillo, et al.
The Journal of Biological Chemistry|December 6, 1996
Selection of potent inhibitors of farnesyl-protein transferase from a synthetic tetrapeptide combinatorial libraryA Wallace, K S Koblan, K Hamilton, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, R Labianca, et al.
Analytical Biochemistry|January 16, 1999
A high-throughput radiometric assay for hepatitis C virus NS3 proteaseM Cerretani, L Di Renzo, S Serafini, et al.
European Journal of Immunology|October 1, 1991
Mycobacterial heat-shock proteins as carrier moleculesA R Lussow, C Barrios, J van Embden, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1987
Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 childrenG Del Giudice, H D Engers, C Tougne, et al.
Journal of Molecular Biology|June 15, 1999
Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studiesD O Cicero, G Barbato, U Koch, et al.
European Journal of Biochemistry|September 5, 2001
ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serumO Minenkova, N Gargano, A De Tomassi, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) studyS Cascinu, S Barni, R Labianca, et al.
British Journal of Cancer|April 20, 2001
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancerA Sobrero, A Guglielmi, M Cirillo, et al.
The Journal of Biological Chemistry|December 6, 1996
Selection of potent inhibitors of farnesyl-protein transferase from a synthetic tetrapeptide combinatorial libraryA Wallace, K S Koblan, K Hamilton, et al.
Pageof 9